Form 8-K - Current report:
SEC Accession No. 0001558370-24-009701
Filing Date
2024-07-09
Accepted
2024-07-09 08:46:25
Documents
16
Period of Report
2024-07-02
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K cydy-20240702x8k.htm   iXBRL 8-K 36516
2 EX-99.1 cydy-20240702xex99d1.htm EX-99.1 13600
3 GRAPHIC cydy-20240702xex99d1001.jpg GRAPHIC 5423
  Complete submission text file 0001558370-24-009701.txt   191987

Data Files

Seq Description Document Type Size
4 EX-101.SCH cydy-20240702.xsd EX-101.SCH 3405
5 EX-101.LAB cydy-20240702_lab.xml EX-101.LAB 16919
6 EX-101.PRE cydy-20240702_pre.xml EX-101.PRE 11938
18 EXTRACTED XBRL INSTANCE DOCUMENT cydy-20240702x8k_htm.xml XML 4261
Mailing Address 1111 MAIN STREET, SUITE 660 VANCOUVER WA 98660
Business Address 1111 MAIN STREET, SUITE 660 VANCOUVER WA 98660 360-980-8524
CytoDyn Inc. (Filer) CIK: 0001175680 (see all company filings)

EIN.: 753056237 | State of Incorp.: DE | Fiscal Year End: 0531
Type: 8-K | Act: 34 | File No.: 000-49908 | Film No.: 241106419
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)